Bristol Myers Squibb’s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase II Study BMS-986278, a potential first-in-class oral lysophosphatidic acid receptor 1 (LPA1) antagonist, was studied in patients with progressive pulmonary fibrosis (PPF)...
Find MorePost-traumatic stress disorder (PTSD) is a disorder that affects a wide range of people and can be triggered by various traumatic events, despite its association with military veterans or active-duty service members. According to the Department of Veterans Affairs, approximately 12 million adults in the United Stat...
Find MoreOver the last decade, various technologies, after being evaluated rigorously, have exhibited competence in treating mental health by becoming an extension of the already present care models. Today, the patient or user can now download a clinical-grade app on the phone, tablet, or computer and use it as a reliable m...
Find MorePost-Traumatic Stress Disorder Awareness Day, a day dedicated to increasing awareness regarding PTSD (Post Traumatic Stress Disorder). It is celebrated annually on 27 June. Post-Traumatic Stress Disorder (PTSD) is a seriously debilitating condition that can develop in a person who has experienced or witnessed a...
Find MoreEye Movement Desensitization and Reprocessing (EMDR) is a psychotherapy treatment or a psychological treatment method, developed by American clinical psychologist, Dr Francine Shapiro, in the 1980s. The therapy is a popular way of treatment used to recover from distressing and disturbing life experiences that resul...
Find MoreFatty acid amide hydrolase (FAAH) belongs to the serine hydrolase family of enzymes. The identification of this enzyme was led by the discovery and characterization of fatty acid amides, including anandamide and oleamide, as a fundamental class of endogenous signaling molecules. FAAH serves as the major metabolic re...
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.